INS and congenital isolated hyperinsulinism: Patients with CHI have increased risk of brain injury secondary to the metabolic actions of insulin, which acts by driving glucose into the insulin sensitive tissues (skeletal muscle and adipose tissue) and by inhibiting glucose production by glycolysis and gluconeogenesis [7].